To receive daily emails from Breaking Christian News to your inbox CLICK HERE


SHARE THIS ARTICLE Printer friendly version of this page

Drug Developed in Israel Saves 47 of 50 Severe Covid Patients in Trial

Abigail Klein Leichman : Nov 29, 2021  ISRAEL21c.org

Bonus BioGroup says its MesenCure experimental treatment resulted in 94% survival rate of trial subjects and cut hospitalization time in half.

[ISRAEL21c.org] Israel's Bonus BioGroup reports a survival rate of 94 percent (47 of 50) of the severe Covid-19 patients treated with its drug product MesenCure in a Phase II, multicenter clinical trial. (Image: Illustrative photo of Covid-19 patient at Kaplan Medical Center in Rehovot, one of three Israeli hospitals that participated in Phase II trials of MesenCure by Bonus BioGroup. /Credit: Yossi Aloni-Flash90 /via ISRAEL21c.org)

Study results, soon to be published, show MesenCure treatment reduced study participants' hospitalization period by about half compared to a control group. All these patients had life-threatening pneumonia and respiratory distress caused by Covid-19.

The data shows that MesenCure treatment reduced mortality by about 70% compared with the control group. Only two of the first 30 severe Covid-19 patients treated with MesenCure died due to Covid-19 or its complications, while 14 of 60 similar patients in the control group died.

MesenCure treatment shortened the hospitalization period of severe Covid-19 patients by eight days on average, a reduction of 45% relative to the control group.

The experimental group included women and men aged 41.4 to 77.4. About 77% of the severe Covid-19 patients treated in three hospitals with MesenCure had one or more risk factors for poor prognosis: hypertension, hyperlipidemia, obesity and Type 2 diabetes. Most were treated during the fourth Covid-19 wave in Israel, dominated by the Delta strain.

The control group received the current standard of care — anti-inflammatory drugs in combination with steroids. This regimen, according to Bonus BioGroup, reduces mortality in hospitalized Covid-19 patients only slightly, from 25.8% to 21.8%, indicating that MesenCure is four times more effective.

"We are proud of our success in leading the world to be a safer place by developing a medication for severe Covid-19 patients, thereby dramatically reducing the threat to their lives," said Dr. Shai Meretzki, CEO of Bonus BioGroup.

"In less than two years from the epidemic outbreak, we are the first in the world to report an effective and significant treatment for severely ill patients."

According to a statement from Bonus BioGroup, an independent expert committee confirmed the findings of the Phase II clinical trial of MesenCure and recommended continuing toward Phase III. Meretzki told the Jerusalem Post that the company will apply for emergency use approval from European and US regulatory agencies. Subscribe for free to Breaking Christian News here







SHARE THIS ARTICLE Printer friendly version of this page

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Other Recent Articles from Breaking Christian News

1,000 Families Expected to Join Mass Lawsuit against Infamous UK Trans Surgery Clinic

'I Asked God to Save Her': Olivia Newton-John Shared Powerful Prayer She Prayed Over Daughter's Life in Final Interview

Pro-Life Win: Indiana Approves Additional $45M to Support Pregnant and Postpartum Women

Which Americans Are Most Likely to be Audited by the IRS Under 'Inflation Reduction Act'?

Beyond Disappointing, Now Egregious: Episcopal Church Completely Sells Out to Trans Agenda, Supporting Sex Changes 'At All Ages'

Insanity: Senate Dems Unanimously Vote Down Inflation Bill Amendment That Affirms Only Women Can Have Babies

Men And Women Harmed By 'Trans' Surgeries Are Sharing Their Stories of Regret, Anxiety and Depression

Little League Playoffs: 'The Greatest Moment in the History of Sportsmanship'

Is Biden Trying to Goad the Right into a Violent Reaction to Mar-a-Largo Raid?

Deeply Flawed Trans Youth Study Shows Desperation of LGBT Activists

Tragic: 4-Year-Old Girl Announces Her 'Gender Transition' at 'Pride' Parade

Consequences: Voters Defund Library over Graphic LGBT Books

Outraged Texas Citizens Stand Up to Mayor's Radical Leftist Agenda to 'Transform' Their City; Gain a Huge Victory

Dutch Sheets: The Re-circuiting Continues

Trans Activist Who Planned to Ship Prescription Hormones to Minors Reported to Authorities by Prominent Conservatives

Public School Teachers Told to Indoctrinate Kids as Young as Three in Radical LGBT Theory

Democrats Creating IRS Army of 87,000 New Enforcers, 700,000 New Audits on Middle-Class Americans

Dangerous Truth: True the Vote Team Needs Your Prayer

Dr. Alveda King: Pray to Avoid Civil War in 21st Century America

Mar-A-Lago Raid: The Complete Sovietization of the Democrat Party



Search the Articles Archives

Keyword:  
Author:  
Words Posted On:  
Day Month Year



BCN Plus

Follow BCN on Twitter
Are You Praying for Our Government Leaders?
BCN Staff

Steve Shultz
Steve Shultz, Managing Editor
Founder and Owner


Aimee Herd
Aimee Herd, Editor


BCN Plus
Are You Praying for President Trump?
 
 

All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.


Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved


Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.

editor@breakingchristiannews.com